Feasibility of Integrating Homeopathic Approach in a Comprehensive Cancer Center
Launched by RAMBAM HEALTH CARE CAMPUS · Apr 15, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether using homeopathy—a type of complementary medicine—can be beneficial for cancer patients receiving care at Rambam Health Campus in Haifa, Israel. The study aims to understand why patients might choose to try homeopathy, how well they accept and follow this treatment, and how it affects their quality of life. Researchers will gather information from participants through questionnaires that help measure their well-being and any distress they may feel.
To participate in this study, individuals must be at least 18 years old, able to read and understand Hebrew, and currently receiving treatment for cancer at the hospital. Participants should be in relatively good health, as determined by their doctor. Those with severe mental health issues or other unstable medical conditions will not be eligible. If you join the study, you can expect to share your thoughts and experiences about homeopathy in a short interview lasting about 15-30 minutes. Overall, this trial aims to explore how integrating homeopathic treatment might improve the lives of cancer patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • 18 years of age or older
- • Ability to read, write, and understand the Hebrew language
- • Patients treated at the Division of Oncology in Rambam Health Campus.
- • Performance status of ECOG 0-2.
- • Consent to participate in the study.
- Exclusion Criteria:
- • • Inability to understand the intent of the study and follow the instructions
- • Diagnosis of active psychosis, altered mental state or severe cognitive impairment confirmed by the patient's attending physician.
- • Frailty, ECOG worse than 2, or other unstable medical conditions as confirmed by the patient's attending physician including acute illness, fever, unclear rash or medical conditions that would preclude participation in an interview session lasting 15-30 minutes
About Rambam Health Care Campus
Rambam Health Care Campus is a leading medical institution located in Haifa, Israel, renowned for its comprehensive patient care, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, Rambam is dedicated to advancing healthcare through innovative research and development, facilitating a wide range of clinical studies across various therapeutic areas. The campus boasts state-of-the-art facilities, a multidisciplinary team of expert researchers and clinicians, and a robust infrastructure that supports rigorous scientific inquiry and ethical standards in clinical trials. By fostering collaboration and leveraging cutting-edge technology, Rambam Health Care Campus aims to enhance treatment options and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Haifa, , Israel
Patients applied
Trial Officials
Maria Suleymanov, RN
Study Director
Rambam Health Care Campus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported